- Home
- HVT vs GOSS Comparison
HVT vs GOSS Comparison
Compare HVT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HVT
- GOSS
- Stock Information
- Founded
- HVT 1885
- GOSS 2015
- Country
- HVT United States
- GOSS United States
- Employees
- HVT N/A
- GOSS N/A
- Industry
- HVT Other Specialty Stores
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- HVT Consumer Discretionary
- GOSS Health Care
- Exchange
- HVT Nasdaq
- GOSS Nasdaq
- Market Cap
- HVT 317.1M
- GOSS 262.5M
- IPO Year
- HVT N/A
- GOSS 2019
- Fundamental
- Price
- HVT $20.21
- GOSS $1.40
- Analyst Decision
- HVT
- GOSS Strong Buy
- Analyst Count
- HVT 0
- GOSS 4
- Target Price
- HVT N/A
- GOSS $7.75
- AVG Volume (30 Days)
- HVT 111.4K
- GOSS 1.3M
- Earning Date
- HVT 07-30-2025
- GOSS 08-11-2025
- Dividend Yield
- HVT 6.37%
- GOSS N/A
- EPS Growth
- HVT N/A
- GOSS N/A
- EPS
- HVT 1.28
- GOSS N/A
- Revenue
- HVT $720,469,000.00
- GOSS $124,590,000.00
- Revenue This Year
- HVT $4.96
- GOSS N/A
- Revenue Next Year
- HVT $8.28
- GOSS $91.14
- P/E Ratio
- HVT $15.69
- GOSS N/A
- Revenue Growth
- HVT N/A
- GOSS N/A
- 52 Week Low
- HVT $17.01
- GOSS $0.55
- 52 Week High
- HVT $29.85
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- HVT 51.57
- GOSS 57.95
- Support Level
- HVT $19.32
- GOSS $1.22
- Resistance Level
- HVT $20.49
- GOSS $1.36
- Average True Range (ATR)
- HVT 0.58
- GOSS 0.08
- MACD
- HVT -0.03
- GOSS -0.00
- Stochastic Oscillator
- HVT 52.98
- GOSS 66.07
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.